Search Results - "Tousignant, J D"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Binding and uptake of cationic lipid:pDNA complexes by polarized airway epithelial cells by Chu, Q, Tousignant, J D, Fang, S, Jiang, C, Chen, L H, Cheng, S H, Scheule, R K, Eastman, S J

    Published in Human gene therapy (01-01-1999)
    “…To better understand the barriers associated with cationic lipid-mediated gene transfer to polarized epithelial cells, Fischer rat thyroid (FRT) cells and…”
    Get more information
    Journal Article
  2. 2

    Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice by Tousignant, J D, Gates, A L, Ingram, L A, Johnson, C L, Nietupski, J B, Cheng, S H, Eastman, S J, Scheule, R K

    Published in Human gene therapy (10-12-2000)
    “…A major limitation associated with systemic administration of cationic lipid:plasmid DNA (pDNA) complexes is the vector toxicity at the doses necessary to…”
    Get more information
    Journal Article
  3. 3

    Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG Motifs by Yew, Nelson S., Zhao, Hongmei, Wu, I-Huan, Song, Antonius, Tousignant, Jennifer D., Przybylska, Malgorzata, Cheng, Seng H.

    Published in Molecular therapy (01-03-2000)
    “…An inflammatory response is invariably associated with administration of gene transfer complexes composed of cationic lipids and plasmid DNA (pDNA). In the…”
    Get full text
    Journal Article
  4. 4

    DNA sequences in cationic lipid:pDNA-mediated systemic toxicities by Tousignant, Jennifer D, Zhao, Hongmei, Yew, Nelson S, Cheng, Seng H, Eastman, Simon J, Scheule, Ronald K

    Published in Human gene therapy (10-02-2003)
    “…Systemic delivery of synthetic gene transfer vectors such as cationic lipid:plasmid DNA (pDNA) complexes elicits a range of acute physiologic responses, which…”
    Get more information
    Journal Article
  5. 5

    Partial correction of the α-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors by Przybylska, Malgorzata, Wu, I-Huan, Zhao, Hongmei, Ziegler, Robin J., Tousignant, Jennifer D., Desnick, Robert J., Scheule, Ronald K., Cheng, Seng H., Yew, Nelson S.

    Published in The journal of gene medicine (01-01-2004)
    “…Background Fabry disease is a recessive, X‐linked disorder caused by a deficiency of the lysosomal enzyme α‐galactosidase A, leading to an accumulation of the…”
    Get full text
    Journal Article
  6. 6

    A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung by Eastman, S J, Lukason, M J, Tousignant, J D, Murray, H, Lane, M D, St George, J A, Akita, G Y, Cherry, M, Cheng, S H, Scheule, R K

    Published in Human gene therapy (10-04-1997)
    “…Advances in gene therapy vectors and techniques hold promise for treatment of many inherited and acquired diseases. For lung indications, especially those…”
    Get more information
    Journal Article
  7. 7

    Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes by Eastman, S J, Tousignant, J D, Lukason, M J, Murray, H, Siegel, C S, Constantino, P, Harris, D J, Cheng, S H, Scheule, R K

    Published in Human gene therapy (10-02-1997)
    “…We have examined several variables inherent in aerosolizing cationic lipid:DNA complexes using a jet nebulizer and thereby have optimized the delivery of…”
    Get more information
    Journal Article
  8. 8

    Aerosolization of cationic lipid:pDNA complexes--in vitro optimization of nebulizer parameters for human clinical studies by Eastman, S J, Tousignant, J D, Lukason, M J, Chu, Q, Cheng, S H, Scheule, R K

    Published in Human gene therapy (01-01-1998)
    “…Previously, we have described the optimization of the aerosol delivery of a nonviral gene therapy vector to the lungs of rodents (Eastman et al., 1997b)…”
    Get more information
    Journal Article
  9. 9

    CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo by Yew, Nelson S., Zhao, Hongmei, Przybylska, Malgorzata, Wu, I-Huan, Tousignant, Jennifer D., Scheule, Ronald K., Cheng, Seng H.

    Published in Molecular therapy (01-06-2002)
    “…Systemic delivery of cationic lipid–plasmid DNA (pDNA) complexes induces an acute inflammatory response with adverse hematologic changes and liver damage…”
    Get full text
    Journal Article